Related Experiment Video
Updated: Jun 16, 2026
09:57
Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
[Epilepsy in the elderly: diagnostic and therapeutic problems].
1Universitätsklinikum Erlangen, Epilepsiezentrum (ZEE). hermann.stefan@neuro.imed.uni-erlangen.de
MMW Fortschritte Der Medizin
|January 29, 2010
Summary
Late-onset epilepsy, diagnosed in individuals 65+, requires careful management. Second-generation antiepileptic drugs are preferred due to better tolerability in older adults.
Area of Science:
- Neurology
- Geriatrics
Background:
- Late-onset epilepsy is defined as epilepsy first appearing at age 65 or older.
- Older adults often have altered pharmacokinetics and pharmacodynamics, increasing risks.
- Coexisting medical conditions are common in the elderly, complicating treatment.
Purpose of the Study:
- To outline the diagnostic and therapeutic considerations for late-onset epilepsy.
- To emphasize the importance of early specialist consultation.
- To recommend preferred antiepileptic drug (AED) classes for elderly patients.
Main Methods:
- Diagnosis involves medical history and electroencephalogram (EEG).
- Therapeutic strategies must account for age-related physiological changes.
- Review of AEDs based on tolerability and efficacy in older populations.
Main Results:
- Lower medication dosages are often necessary in the elderly.
- Adverse drug reactions are a significant concern due to comorbidities.
- Second-generation AEDs (lamotrigine, topiramate, levetiracetam) show better tolerability.
- First-generation AEDs (carbamazepine, phenytoin, phenobarbital, primidone) are less preferred.
Conclusions:
- Late-onset epilepsy necessitates tailored treatment approaches.
- Prioritizing second-generation AEDs improves safety and tolerability in older adults.
- Careful dosage adjustment and monitoring for adverse effects are crucial.
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
01:22Epilepsy ll: Types
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:20Seizures l: Introduction
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...